AMI Co.

Redefining auscultation with AI-powered cardiac diagnosis

Kagoshima, Japan · Founded 2015 · $6.7M raised

Headquarters
Kagoshima
Employees
1–10
Founded
2015
Business Model
B2B
Website
ami.inc
Total Funding
$6.7M
Last Round
$6.7M Series BJul 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

AMI Co. (Acute Medical Innovation) is a Japanese medical technology company developing an AI-powered super-stethoscope capable of simultaneously capturing heart sounds and ECG signals for automated cardiac disease diagnosis. The company's flagship product, Cardio-EGG, uses deep learning to assist diagnosis of heart disease from phonocardiographic and electrocardiographic data, enabling task-shifting to non-physician healthcare workers and remote medical support. Founded in Kumamoto, Japan, AMI holds ISO 27001 certification and has received multiple awards from national healthcare and entrepreneurship programs.

Summary

AMI Co. is an Artificial Intelligence company based in Kagoshima, Japan, founded in 2015. It has raised $6.7M in total across 2 rounds, most recently a $6.7M Series B round in Jul 2023. Investors include Development Bank of Japan.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJul 2023
$6.7M

Sign up to see all 2 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AMI Co. on Indexed.vc
<a href="https://indexed.vc/companies/ami-co"><img src="https://indexed.vc/api/badge/company/ami-co" alt="AMI Co. on Indexed.vc" width="260" height="76" /></a>